AGL agilon health, inc.

NYSE agilonhealth.com


$ 1.02 $ 0.11 (11.55 %)    

Wednesday, 15-Oct-2025 18:53:58 EDT
QQQ $ 603.31 $ 4.22 (0.71 %)
DIA $ 463.35 $ 0.00 (0 %)
SPY $ 665.78 $ 2.94 (0.44 %)
TLT $ 90.74 $ -0.20 (-0.22 %)
GLD $ 387.70 $ 6.60 (1.73 %)
$ 1.02
$ 0.93
$ 1.02 x 1
$ 1.05 x 47
$ 0.93 - $ 1.10
$ 0.71 - $ 6.08
9,638,697
na
422.71M
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-04-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 02-25-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 03-03-2022 12-31-2021 10-K
16 10-28-2021 09-30-2021 10-Q
17 08-04-2021 06-30-2021 10-Q
18 05-26-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wells-fargo-maintains-overweight-on-agilon-health-lowers-price-target-to-15

Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and lowers the price target from $5 ...

 bernstein-downgrades-agilon-health-to-market-perform-lowers-price-target-to-14

Bernstein analyst Lance Wilkes downgrades Agilon Health (NYSE:AGL) from Outperform to Market Perform and lowers the price ta...

 jefferies-maintains-hold-on-agilon-health-lowers-price-target-to-11

Jefferies analyst Jack Slevin maintains Agilon Health (NYSE:AGL) with a Hold and lowers the price target from $2.4 to $1.1.

 benchmark-maintains-buy-on-agilon-health-lowers-price-target-to-15

Benchmark analyst Bill Sutherland maintains Agilon Health (NYSE:AGL) with a Buy and lowers the price target from $4 to $1.5.

 barclays-maintains-underweight-on-agilon-health-lowers-price-target-to-15

Barclays analyst Andrew Mok maintains Agilon Health (NYSE:AGL) with a Underweight and lowers the price target from $3 to $1.5.

 citigroup-downgrades-agilon-health-to-neutral-lowers-price-target-to-1

Citigroup analyst Daniel Grosslight downgrades Agilon Health (NYSE:AGL) from Buy to Neutral and lowers the price target from...

 agilon-health-q2-eps-025-misses-012-estimate-sales-1395b-miss-1472b-estimate

Agilon Health (NYSE:AGL) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.12) ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION